Biblio

Author Title [ Type(Desc)] Year
Filters: Author is Hulot, Jean-Sébastien  [Clear All Filters]
Journal Article
Turnbull IC, Karakikes I, Serrao GW, Backeris P, Lee J-J, Xie C, Senyei G, Gordon RE, Li RA, Akar FG, et al. Advancing functional engineered cardiac tissues toward a preclinical model of human myocardium. FASEB J. 2013.
Sayed ZRAl, Pereira C, Le Borgne R, de Lesegno CViaris, Jouve C, Pénard E, Mallet A, Masurkar N, Loussouarn G, Verbavatz J-M, et al. CAVIN1-Mediated hERG Dynamics: A Novel Mechanism Underlying the Interindividual Variability in Drug-Induced Long QT. Circulation. 2024.
Vermersch E, Jouve C, Hulot J-S. CRISPR/CAS9 Gene-Editing Strategies in Cardiovascular Cells. Cardiovasc Res. 2019.
Hulot J-S, Vermersch E, Jouve C. CRISPRed Cardiomyocytes to Decrypt Variants of Uncertain Significance. J Am Coll Cardiol. 2018;72(1):76-78.
Fontaine V, Duboscq-Bidot L, Jouve C, Hamlin M, Curjol A, Briand V, Janiak P, Hulot J-S, Pruniaux-Harnist M-P, Charron P, et al. Generation of iPSC line from MYH7 R403L mutation carrier with severe hypertrophic cardiomyopathy and isogenic CRISPR/Cas9 corrected control. Stem Cell Res. 2021;52:102245.
Karakikes I, Senyei GD, Hansen J, Kong C-W, Azeloglu EU, Stillitano F, Lieu DK, Wang J, Ren L, Hulot J-S, et al. Small Molecule-Mediated Directed Differentiation of Human Embryonic Stem Cells Toward Ventricular Cardiomyocytes. Stem Cells Transl Med. 2013.
de Boer RA, Heymans S, Backs J, Carrier L, Coats AJS, Dimmeler S, Eschenhagen T, Filippatos G, Gepstein L, Hulot J-S, et al. Targeted therapies in genetic dilated and hypertrophic cardiomyopathies: From molecular mechanisms to therapeutic targets. Eur J Heart Fail. 2021.
Wu JC, Garg P, Yoshida Y, Yamanaka S, Gepstein L, Hulot J-S, Knollmann BC, Schwartz PJ. Towards Precision Medicine With Human iPSCs for Cardiac Channelopathies. Circ Res. 2019;125(6):653-658.
Seguret M, Davidson P, Robben S, Jouve C, Pereira C, Lelong Q, Deshayes L, Cerveau C, Le Berre M, Ribeiro RSRodrigue, et al. A versatile high-throughput assay based on 3D ring-shaped cardiac tissues generated from human induced pluripotent stem cell-derived cardiomyocytes. Elife. 2024;12.